Enhancement of clonogenicity of human multiple myeloma by dendritic cells
about
Clonogenic multiple myeloma progenitors, stem cell properties, and drug resistanceImmune Modulation in Hematologic MalignanciesTargeting the biophysical properties of the myeloma initiating cell niches: a pharmaceutical synergism analysis using multi-scale agent-based modelingCancer immunotherapy via dendritic cellsFunctional interaction of plasmacytoid dendritic cells with multiple myeloma cells: a therapeutic target.Tumor-associated macrophages infiltrate plasmacytomas and can serve as cell carriers for oncolytic measles virotherapy of disseminated myeloma.Identification of translocation products but not K-RAS mutations in memory B cells from patients with multiple myeloma.Advances in the understanding of myeloma bone disease and tumour growth.Immunity to stemness genes in human cancer.A novel TLR-9 agonist C792 inhibits plasmacytoid dendritic cell-induced myeloma cell growth and enhance cytotoxicity of bortezomib.Bone marrow microenvironment in myelomagenesis: its potential role in early diagnosis.Dendritic cell subsets in health and disease.Induction of malignant plasma cell proliferation by eosinophilsSustained antibody responses depend on CD28 function in bone marrow-resident plasma cellsPhenotypic, genomic and functional characterization reveals no differences between CD138++ and CD138low subpopulations in multiple myeloma cell linesDendritic cells and malignant plasma cells: an alliance in multiple myeloma tumor progression?Mass cytometry analysis shows that a novel memory phenotype B cell is expanded in multiple myeloma.Bortezomib enhances dendritic cell (DC)-mediated induction of immunity to human myeloma via exposure of cell surface heat shock protein 90 on dying tumor cells: therapeutic implicationsCD28-mediated regulation of multiple myeloma cell proliferation and survival.Dendritic cell-mediated activation-induced cytidine deaminase (AID)-dependent induction of genomic instability in human myeloma.Dendritic cells accumulate in the bone marrow of myeloma patients where they protect tumor plasma cells from CD8+ T-cell killing.Treatment with 5-Aza-2'-Deoxycytidine Induces Expression of NY-ESO-1 and Facilitates Cytotoxic T Lymphocyte-Mediated Tumor Cell Killing.Bone marrow microenvironment and the identification of new targets for myeloma therapy.Frequent and specific immunity to the embryonal stem cell-associated antigen SOX2 in patients with monoclonal gammopathyChimeric Antigen Receptor T Cells against CD19 for Multiple MyelomaMolecular pathogenesis of multiple myeloma and its premalignant precursor.Stemness of B-cell progenitors in multiple myeloma bone marrow.MHC class I chain-related protein A antibodies and shedding are associated with the progression of multiple myeloma.Dissecting the multiple myeloma-bone microenvironment reveals new therapeutic opportunitiesPSGL-1/selectin and ICAM-1/CD18 interactions are involved in macrophage-induced drug resistance in myeloma.Dendritic cells mediate the induction of polyfunctional human IL17-producing cells (Th17-1 cells) enriched in the bone marrow of patients with myelomaInteractions of tumor cells with dendritic cells: balancing immunity and toleranceCancer stem cells in hematopoietic malignancies.Circulating clonotypic B cells in classic Hodgkin lymphomaThe Janus face of dendritic cells in cancer.Syndecan-1 is required for robust growth, vascularization, and metastasis of myeloma tumors in vivoDominant role of CD47-thrombospondin-1 interactions in myeloma-induced fusion of human dendritic cells: implications for bone disease.Microenvironment-dependent growth of preneoplastic and malignant plasma cells in humanized mice.Atacicept (TACI-Ig) inhibits growth of TACI(high) primary myeloma cells in SCID-hu mice and in coculture with osteoclasts.Harnessing human dendritic cell subsets for medicine.
P2860
Q24644883-66FFE63A-EB19-43F4-90B0-AABD81CE9ACEQ26796307-2AE48450-C10B-4BE8-B240-28DB99569E02Q27334339-5E252052-D6FB-4286-A2AD-01EF32A18775Q29615444-4E9C2D22-EEF2-40CA-B076-B8651FF6FC1DQ30490975-F8B49492-F80C-42FB-9107-52EA228B5A85Q33585559-F23E6004-E851-4CE2-AF47-C7333FD12F92Q33590627-F9AA01F0-99A8-49E6-94D1-6F6780B30C2FQ33829022-101A3E7E-8DEA-4956-ADD2-9DFA45CD401DQ33943241-EF729452-E5EB-4F4A-A8D5-FEF2B671B197Q33976734-F35FE350-EA6F-4C3E-AC53-97DDB3F82B47Q34155848-4504B95E-9A32-4048-8C9E-038F02036839Q34582889-0F5A9CF5-5367-4F4F-B00E-9762079D4038Q34876626-B88952BB-06C0-4765-A6DE-48825B7B6926Q35102323-E295BE7A-B1ED-4A02-86FC-2F941B1EA795Q35128148-87C311FC-3276-47F8-BEAF-F65963A72D91Q35584599-86056D5C-571A-49A1-BBC1-24B807E67512Q35688965-F608936F-32C3-4985-BB65-ABC51DEC7B56Q35828762-99F1DB95-712C-4B11-BA12-3D16B134CD50Q35828826-AA61E38F-45E6-478D-83D9-34970F15DC19Q35849249-B0FFBDEE-1204-4E35-8642-8BCD4282CC54Q36117230-3B436569-FCCA-479C-9D89-600C7DE687FBQ36136992-C6D75B46-CE18-4FD6-9225-C7D2D5509576Q36162703-60340463-113D-47BF-86C0-5E807F50B486Q36229280-8ED4E045-42B5-4169-BCCE-CA0E462DDE1DQ36284584-7FEDBFCC-F265-437B-9F92-32327499AD93Q36290238-E9AD23FE-BD6D-45D0-A666-57625B6D3735Q36405908-DF9FA572-F125-4834-8292-CBE7C6E76929Q36446189-42D5A6C5-FC77-45EA-A397-C6E252F2CE55Q36447553-32F35882-E48E-45C4-AD44-B484E962A542Q36839558-A11C12E3-CB5C-4A7E-A7E0-BB4E264FE0CFQ36915925-E312F871-C9D5-4782-9084-56883701F492Q36975749-144682A2-DAFD-474F-A414-0DBF0FDDBE1CQ37045904-6E9BB53D-BEE7-48FF-8D82-BCA50D6A68C9Q37237474-BC51C223-8CF8-4315-952E-FC5510F5678CQ37287170-3E3B1065-F98B-469F-BF51-598D2055ECB6Q37377754-B3AB9877-AC44-4065-9F04-AE2886530A55Q37396070-B108DDDB-9636-4636-9C36-B06ECC73C9BCQ37402009-4EFA06CC-9C42-4870-81FB-2FCD28A88D39Q37407676-3B6FD5F9-F1D5-4BF6-AB7B-694D619AF67CQ37700841-AB8A94D4-40E5-472C-AEE9-297A25073D39
P2860
Enhancement of clonogenicity of human multiple myeloma by dendritic cells
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Enhancement of clonogenicity of human multiple myeloma by dendritic cells
@ast
Enhancement of clonogenicity of human multiple myeloma by dendritic cells
@en
type
label
Enhancement of clonogenicity of human multiple myeloma by dendritic cells
@ast
Enhancement of clonogenicity of human multiple myeloma by dendritic cells
@en
prefLabel
Enhancement of clonogenicity of human multiple myeloma by dendritic cells
@ast
Enhancement of clonogenicity of human multiple myeloma by dendritic cells
@en
P2093
P2860
P356
P1476
Enhancement of clonogenicity of human multiple myeloma by dendritic cells
@en
P2093
Aisha Hutchinson
Amitabha Mazumder
Anjli Kukreja
David Vesole
Kavita Dhodapkar
Madhav V Dhodapkar
Revathi Angitapalli
Sundar Jagannath
P2860
P304
P356
10.1084/JEM.20052136
P407
P577
2006-07-31T00:00:00Z